Journal of the Neurological Sciences
Volume 217, Issue 1 , Pages 17-24 , 15 January 2004

α-Keto-β-methylvaleric acid increases the in vitro phosphorylation of intermediate filaments in cerebral cortex of young rats through the gabaergic system

Received 7 April 2003 ,Revised 14 July 2003 ,Accepted 5 August 2003.

References 

  1. Paramio JM, Jorcano JL. Beyond structure: do intermediate filaments modulate cell signalling?. Bioessays. 2002;24:836–844
  2. Ackerley S, Grierson AJ, Brownlees J, Thornhiel P, Anderton BH, Leight PN, et al.  Glutamate slow axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 2000;150:165–175
  3. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem. Res. 2000;1439–1451
  4. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. The cytoskeleton. In:  Alberts B,  Johnson A,  Lewis J,  Raff M,  Roberts K,  Walter P editor. Molecular biology of the cell. New York: Garland Science; 2002;p. 907–982
  5. Nixon RA, Sihag RK. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 1991;14:501–506
  6. Sihag RK, Nixon RA. Phosphorylation of the amino terminal head domain of the middle molecular mass 145 kDa subunit of neurofilaments. J. Biol. Chem. 1990;265:4166–4171
  7. Inagaki M, Nishi Y, Nishizawa K, Matsuyama M, Sato C. Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature. 1987;328:649–652
  8. Inagaki M, Gonda Y, Nishizawa K, Kitamura S, Sato C, Ando S. Phosphorylation sites linked to glial filament disassembly in vitro located in a non-alpha-helical head domain. J. Biol. Chem. 1990;265:4722–4729
  9. Inada H, Goto H, Tanabe K, Nishi Y, Kaibuchi K, Inagaki M. Rho-associated kinase phosphorylates desmin, the myogenic intermediate filament protein, at unique amino-terminal sites. Biochem. Biophys. Res. Commun. 1998;253:21–25
  10. Ku NO, Omary MB. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 1997;272:7556–7564
  11. Tanaka J, Ogawara M, Ando S, Shibata M, Yatani R, Kusagawa M. Phosphorylation of a 62 kd porcine alpha-internexin, a newly identified intermediate filament protein. Biochem. Biophys. Res. Commun. 1993;196:115–123
  12. Hashimoto R, Nakamura Y, Goto H, Wada Y, Sakoda S, Kaibuchi K. Domain- and site-specific phosphorylation of bovine NF-L by Rho-associated kinase. Biochem. Biophys. Res. Commun. 1998;245:407–411
  13. Peter M, Sanghera JS, Pelech SS, Nigg EA. Mitogen-activated protein kinases phosphorylate nuclear lamins and display sequence specificity overlapping that of mitotic protein kinase p34 cdc2. Eur. J. Biochem. 1992;205:287–294
  14. Hisanaga S, Yasugawa S, Yamakawa T, Miyamoto E, Ikebe M, Uchiyama M, et al.  Dephosphorylation of microtubule-binding sites at the neurofilament-H tail domain by alkaline, acid, and protein phosphatases. J. Biochem. (Tokio). 1993;113:705–709
  15. Shetty KT, Kink WT, Pant HC. Cdc-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. U. S. A. 1993;90:6844–6848
  16. Guidato S, Tsai LH, Woodgett J, Miller CC. Differential cellular phosphorylation of neurofilament heavy side arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 1996;66:1698–1706
  17. Sun D, Leung CL, Liem RKH. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 1996;271:14245–14251
  18. Leterrier JF, Kas J, Hartwig J, Vegners R, Janmey PA. Mechanical effects of neurofilament cross-bridges.Modulation by phosphorylation, lipids, and interactions with F-actin. J. Biol. Chem. 1996;271:15687–15694
  19. Hsieh ST, Kidd GJ, Crawforg TO, Xu Z, Lin WM, Trapp BD, et al.  Regional modulation of neurofilament organization by myelination in normal axons. J. Neurosci. 1994;14:6392–6401
  20. Gotow T, Tanaka T, Nakamura Y, Takeda M. Dephosphorylation of the largest neurofilament subunit protein influences the structure of crossbridges in reassembled neurofilaments. J. Cell Sci. 1994;107:1949–1957
  21. Chuang DT, Shih VE. Disorders of branched chain amino acid and keto acid metabolism. In:  Scriver CR,  Beaudet AL,  Sly WL,  Valle D editor. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001;p. 1971–2005
  22. Snyderman SE, Goldstein F, Sansariq C, Norton PM. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease. Pediatr. Res. 1984;18:851–853
  23. Patel MS, Harris RA. Mammalian alpha-keto acid dehydrogenase complexes: gene regulation and genetic defects. FASEB. 1995;9:1164–1172
  24. Treacy E, Clow CL, Ready TR, Chitayat D, Mamer OA, Scriver CR. Maple syrup urine disease: interrelationship between branched chain amino-, oxo-, and hydroxyacids; implications for treatment; association with CNS dysmyelination. J. Inherit. Metab. Dis. 1992;15:121–135
  25. Funchal C, de Lima Pelaez P, Oliveira Loureiro S, Vivian L, Dall Bello Pessutto F, Vieira de Almeida LM, et al.  α-Ketoisocaproic acid regulates phosphorylation of intermediate filaments in postnatal rat cortical slices through ionotropic glutamate receptors. Dev. Brain. Res. 2002;139:267–276
  26. Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience. 2000;97:505–519
  27. DeLorey TM, Olsen RW. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res. 1999;36:123–132
  28. Borsook D, Richardson GS, Moore-Ede MC, Brennan MJ. GABA and circadian timekeeping: implications for manic-depression and sleep disorders. Med. Hypotheses. 1986;19:185–198
  29. Yu TS, Wang SD, Liu JC, Yin HS. Changes in the gene expression of GABA(A) receptor alpha 1 and alpha 2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts. Exp. Neurol. 2001;168:231–241
  30. Ryan JM. Pharmacologic approach to aggression in neuropsychiatric disorders. Semin. Clin. Neuropsychiatry. 2000;5:238–249
  31. Paz MM, Valente GB, Tasca C, de Mattos AG, Pessoa-Pureur R. Malnutrition induces an increase in intermediate filament protein content of rat cerebral cortex. J. Nutr. 1991;121:1349–1354
  32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–267
  33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;277:680–685
  34. Branco T, Meirelles R, Bevilaqua da Rocha B, de Mattos-Dutra A, Wajner M, Pessoa-Pureur R. Alpha-ketoisicaproate increases the in vitro 32P incorporation into intermediate filaments in cerebral cortex of rats. NeuroReport. 2000;11:3546–3550
  35. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (h-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 1990;265:5267–5272
  36. Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H. Kn62, 1-N,O-Bis-[(5-isoquino-linesulfonyl)-N-methy-(-tyrisyl)]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 1990;265:5315–5320
  37. de Freitas MS, de Mattos AG, Camargo MM, Wannmacher CMD, Pessoa-Pureur R. Cytoskeletal-associated protein kinase and phosphatase activities from cerebral cortex of young rats. Neurochem. Res. 1995;20:951–956
  38. Olsen RW, DeLorey TM. GABA and glicine. In:  Siegel GJ,  Agranoff BW,  Albers RW,  Fisher SK,  Uhler MD editor. Basic neurochemistry. New York: Lippincott-Raven; 1999;p. 335–346
  39. MacDonald RL, Olsen RW. GABAA receptor channels. Annu. Rev. Neurosci. 1994;17:569–602
  40. Johnston GAR. GABAC receptors: relatively simple transmitter-gated ion channels?. Trends Pharmacol. Sci. 1996;17:319–323
  41. Wang H, Olsen RW. Binding of the GABA(A) receptor-associated protein (GABARAP) to microtubules and microfilaments suggests involvement of the cytoskeleton in GABARAPGABA(A) receptor interaction. J. Neurochem. 2000;75:644–655
  42. Ho WH, Wang SM, Yin HS. Regulation of the subcellular distribution and gene expression of GABA(A) receptor by microtubules and microfilaments in cultured brain neurons. J. Cell Biochem. 2001;83:291–303
  43. Porter JT, McCarht KD. Astrocytic neurotransmitter receptors in situ and in vivo. Progr. Neurobiol. 1997;51:439–455
  44. Runquist M, Alonso G. Gabaergic signaling mediates the morphological organization of astrocytes in the adult rat forebrain. Glia. 2003;41:137–151
  45. Rosewater K, Sontheimer H. Fibrous and protoplasmic astrocytes express GABAA receptors that differ in benzodiazepine pharmacology. Brain Res. 1994;636:73–80
  46. Ben-Ari Y. Developing networks play a similar melody. TRENDS Neurosci. 2001;24:353–360
  47. Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat. Rev. Neurosci. 2002;3:728–739
  48. Gaiarsa JJ, Caillard O, Ben-Ari Y. Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance. TRENDS Neurosci. 2002;25:564–570
  49. Brandt R. Cytoskeleton mechanisms of neuronal deterioration. Cell Tissue Res. 2001;305:255–265

PII: S0022-510X(03)00240-5

doi: 10.1016/j.jns.2003.08.003

Journal of the Neurological Sciences
Volume 217, Issue 1 , Pages 17-24 , 15 January 2004

Article Tools

* Image Usage & Resolution